Morgan Stanley Sea Spine Holdings Corp Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.01 - $8.35 $292,993 - $407,070	-48,751 Reduced 20.7%	186,716 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.46 $736,916 - $986,965	132,301 Added 128.24%	235,467 $1.34 Million
Q2 2022 Oct 27, 2022	BUY	$5.65 - $12.19 $399,387 - $861,686	70,688 Added 217.65%	103,166 $582,000
Q2 2022 Aug 15, 2022	BUY	$5.65 - $12.19 $399,387 - $861,686	70,688 Added 217.65%	103,166 $582,000
Q1 2022 Oct 27, 2022	SELL	$10.93 - $14.05 $772,619 - $993,166	-70,688 Reduced 68.52%	32,478 $396,000
Q1 2022 May 13, 2022	SELL	$10.93 - $14.05 $30,636 - $39,382	-2,803 Reduced 7.94%	32,478 $396,000
Q4 2021 Feb 14, 2022	SELL	$12.24 - $16.31 $251,825 - $335,561	-20,574 Reduced 36.83%	35,281 $480,000
Q3 2021 Nov 15, 2021	BUY	$14.72 - $20.66 $822,185 - $1.15 Million	55,855 New	55,855 $879,000

767K

Ticker SPNE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,202,800
Description
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion pr...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.